Sphingolipid Profiling: A Promising Tool for Stratifying the Metabolic Syndrome-Associated Risk
Metabolic syndrome (MetS) is a multicomponent risk condition that reflects the clustering of individual cardiometabolic risk factors related to abdominal obesity and insulin resistance. MetS increases the risk for cardiovascular diseases (CVD) and type 2 diabetes mellitus (T2DM). However, there stil...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2022-01-01
|
| Sarja: | Frontiers in Cardiovascular Medicine |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.785124/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|